Real-world results for blockbuster weight-loss meds like Ozempic, Wegovy and Zepbound aren't as impressive as those promised ...

Results also show that more than 4 in 5 (81%) of patients were prescribed a low maintenance dose of their GLP-1 drug, and ...

ABC News' Dr. Tara Narula explains a new study indicating that stopping GLP 1 weight loss medications too soon could make it ...

McDonald’s stock was heading for its longest losing streak in 12 years after Redburn Atlantic recommended investors sell due ...

Compounded GLP-1s are still accessible on telehealth sites, despite an agreement with Eli Lilly to cease copycat sales.

Hims & Hers leverages ZAVA's expertise to enter Europe's weight-loss market, boosting growth and profitability. Read what ...

A recent study revealed that popular weight-loss drugs GLP-1 such as Ozempic, Wegovy and Zepbound produce lower weight loss ...

Real-world study shows injectable GLP-1 drugs for obesity have lower weight loss due to treatment discontinuation.

The use of weight loss drugs like Ozempic and Wegovy has surged in recent years. But the medications are not foolproof, as ...

Weight-loss drugs are suppressing appetites for millions of Americans, threatening to upend dining habits at fast-food chains ...

Updated Virtual Weight Loss Platform Expands Access to GLP-1 Support and Clinician-Guided Obesity Care Across All 50 States.

As more Americans turn to GLP-1 drugs like Ozempic to lose weight, McDonald’s could see as much as a $428m annual impact to ...